INTRODUCTION
Ovarian Granulosa Cell Tumors (GCT) is a potentially malignant tumor. Its diagnosis is made by histology after surgical excision and staging according to International Federation of Gynecology and Obstetrics (FIGO) criteria, being the most important prognostic factor. It is a tumor with good prognosis, 90% are diagnosed at stage I; metastases rarely occur. The 5-year survival for stage I patients is above 90%, 55-75% in Stage II and 20-50% in Stage III. Although, large tumor size and breakage are associated with worse prognosis and risk of recurrence. Relapses may be delayed beyond 10 to 20 years of diagnosis.
1 This brief review reports two IA. No adjuvant treatment was indicated, currently free of disease.
Second case is a 59-year old woman diagnosed of a GCT tumor and underwent an incomplete surgery (only ovarian cystectomy by laparotomy) in a different centre in 1995, FIGO stage IC, without adjuvant therapy, multiple surgeries for abdominal relapse. In 2008 she first came to our institution, she had a multiple peritoneal relapse treated with a complete debulking surgery by laparotomy and adjuvant chemotherapy (6 courses of carboplatin-paclitaxel). In July 2014 appears again a 25mm retroperitoneal relapse so she started chemotherapy with Orteronel till May 2015. Tomography shown persistence of a 45mm retroperitoneal mass next to the aortic bifurcation, the patient referred muscle weakness in the lower limbs associated with compression of lumbar roots L4-L5 ( Figure 1 ). We performed a laparoscopic extraperitoneal paraortic lymphadenectomy with removal of the cystic lesion located at left infrarenal level. 32 tumor-free lymph nodes were obtained, cystic lesion containing multiple tumor nests and extracapsular infiltration that supports GCT variety adult. No adjuvant therapy, currently free of disease.
DISCUSSION
GCT is a sex cord-stromal ovarian tumor, more frequent in peri-menopausal age group. Most cases of GCT are detected in early stages, as discussed. The conventional treatment remains complete surgical excision. In young women with stage IA fertility preservation is possible after discarding concomitant endometrial cancer or hyperplasia due to the hyperestrogenism hormonal stimulation caused by the tumor.
2 Also due to the rarity of lymph node metastases in the initial diagnosis, it is suggested that the pelvic and paraortic lymphadenectomy can be omitted as part of the surgical staging. 3, 4 The malignant potential of these tumors is in the high frequency of relapses, which can occur very late, and poor response to chemotherapy.
The gross appearance is that of a unilateral, hard, yellow and highly vascular mass. The characteristic growth pattern of well differentiated Granulosa Cells (less than ten mitoses per high-power field), small, uniform, pale, round or oval, with small nuclei and central slot feature shaped coffee beans. These tumor cells are surrounded by abundant stromal component forming small cystic areas of fluid and cellular debris called Call-Exner bodies, found in 50% of GCTs. Inhibina-A is a high sensitive and specific biomarker of GCT and prognostic factor in the ovary (Figure 2a-d) . Because it is difficult to distinguish GCTs from epithelial ovarian tumors pre-operatively, specially clear cell carcinoma, and there is a low-accuracy of intraoperative pathological diagnosis, the surgical procedure would be the same as suspected of epithelial ovarian cancer. 1 Regarding adjuvant therapy, there is no standard treatment. Some centres recommend platinum based regimens, 2,3 others suggest therapy only when residual disease after surgery or in recurrences, as with the second patient presented in this report.
3 Recent reviews suggest that BEP (bleomycin plus etoposide and cisplatin), GnRH analogues or antiestrogen therapy is an effective regimen after surgery in stages over IC, this is also recommended for recurrent disease after surgical excision. 1 Nevertheless, surgical resection was essential in handling both cases, actually without adjuvant therapy and free of disease. 
